MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Setanaxib

CAS No. : 1218942-37-0

MCE 国际站：Setanaxib

产品活性：Setanaxib (GKT137831) 是选择性的NADPH氧化酶 (NOX1/4) 抑制剂，K_i 分别为140和110nM。

研究领域：Metabolic Enzyme/Protease  |  Apoptosis

作用靶点：NADPH Oxidase  |  Ferroptosis

In Vitro: Setanaxib (GKT137831) is a potent Nox1/4 inhibitor (K_is=140±40/110±30 nM). Administration of Setanaxib (GKT137831) throughout the 72-hour period of normoxia or hypoxia exposure attenuates HPASMC proliferation under normoxic conditions at the 20 μM concentration but had no effect on proliferation in normoxic HPAECs. In the prevention paradigm, Setanaxib (GKT137831) attenuates hypoxia-induced HPASMC and HPAEC proliferation at 5 and 20 μM. Complementary assays of cell proliferation measuring the expression of PCNA or manual cell counting confirmed that Setanaxib (GKT137831) attenuates hypoxia-induced pulmonary vascular cell proliferation.

In Vivo: During the last half of CCl₄ injections, some mice are treated with Setanaxib (GKT137831) daily. CCl₄-induced liver fibrosis is more pronounced in SOD1mu compared to WT mice. Liver fibrosis in both SOD1mu and WT mice is attenuated by Setanaxib (GKT137831) treatment. The increased hepatic α-SMA expression is markedly decreased in SOD1mu mice treated with Setanaxib (GKT137831), to a level similar to that of WT mice given the NOX1/4 inhibitor.

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Apoptosis Compound Library  |  Immunology/Inflammation Compound Library  |  Metabolism/Protease Compound Library  |  Clinical Compound Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  Antioxidant Compound Library  |  Oxygen Sensing Compound Library  |  Anti-Cardiovascular Disease Compound Library  |  Ferroptosis Compound Library  |  Anti-COVID-19 Compound Library  |  Orally Active Compound Library  |  Glutamine Metabolism Compound Library  |  Anti-Cancer Metabolism Compound Library  |  Glucose Metabolism Compound Library  |  Rare Diseases Drug Library  |  Human Metabolite Library  |  Anti-Pulmonary Fibrosis Compound Library  |  Heterocyclic Compound Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Highly Selective Inhibitors Library  |  Sorafenib-d₄  |  Lapatinib ditosylate  |  Ciclopirox olamine  |  Curcumin  |  L-Glutamine-d₅  |  HDAC-IN-48  |  (S)-L-Cystine-¹⁵N₂  |  L-Glutamine-¹³C₅,¹⁵N₂  |  Lapatinib-d₇ dihydrochloride  |  Sorafenib Tosylate  |  Deferiprone  |  Cycloheximide  |  Pravastatin sodium  |  YL-939  |  (-)-Epicatechin  |  Dopamine-d₅ hydrochloride  |  Linagliptin-d₄  |  Acetylcysteine-d₃  |  Dopamine hydrochloride  |  (E)-Ferulic acid  |  PD146176  |  Pifithrin-β hydrobromide  |  ML171  |  Pseudolaric Acid B  |  L-Glutamic acid-d₅  |  Roxadustat  |  Matrine  |  Liproxstatin-1  |  L-Glutamic acid-¹³C₅,¹⁵N,d₅

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物  |  寡核苷酸  |  抗体  |  点击化学

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种全球独家化合物库，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。